Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registrySalomon M. Stemmer, Noa Ben-Baruch, Mariana Steiner et al.|npj Breast Cancer|2017Cited by 87
Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registrySalomon M. Stemmer, Nicky Liebermann, Noa Ben-Baruch et al.|npj Breast Cancer|2017Cited by 70
Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancerElla Evron, Benjamin W. Corn, A. Ben-David et al.|Annals of Oncology|2018Cited by 56
The 21-Gene Recurrence Score Assay (Oncotype DX™) in Estrogen Receptor-Positive Male Breast Cancer: Experience in an Israeli CohortTal Grenader, David Geffen, Rinat Yerushalmi et al.|Oncology|2014Cited by 44
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapySalomon M. Stemmer, David Geffen, Mariana Steiner et al.|npj Breast Cancer|2019Cited by 30